Why So Many Adults Have Depression But Never Get Help

§I.The quiet problem

A staggering number of US adults experience depression each year. In 2024, about 21.4 million adults in the United States had what clinicians call a major depressive episode — a stretch of weeks in which low mood, loss of interest, or both showed up alongside enough other symptoms to meet a clinical threshold. That is roughly 8 in every 100 adults in a single year. Over the course of a lifetime, the number rises further: closer to 1 in 5.

Of all US adults with any mental illness in 2024 — about 61.5 million people — roughly 48% received no treatment of any kind. Not therapy. Not medication. Not even a single conversation with a clinician about what they were experiencing.

The gap is not for lack of effective options. Depression is one of the most studied and most treatable mental health conditions in modern medicine. Multiple independent treatment pathways — psychotherapy, behavioral activation, exercise, medication, mindfulness-based approaches, and combinations of these — have been validated across decades of randomized trials. Effect sizes for the best-evidenced therapies are moderate to large, and most people who engage with treatment improve, even if the path is rarely linear. The science is clear. The access, the recognition, and the follow-through are not.

This post is for the half who do not currently have help. It is also for the people close to them.

What follows is a research-grounded but plain-language walkthrough of what depression actually is, how to recognize it in yourself or someone close to you, what the evidence says actually helps, and what realistic action sequences look like — from I think this might be me to I have a plan to I have a routine. It is not a screening test, though it points to one near the end. It is not a substitute for clinical care. It is a more honest companion to the moment a person sits down at their laptop and types "am I depressed" into a search bar.

A few notes about how to read it.

First: depression is not the same as sadness, and the two are often confused. Most people use the word "depressed" colloquially to mean a sad mood — a bad week, a hard breakup, the gray weight of January. Clinical depression is something more specific. It involves a cluster of symptoms — not just mood, but sleep, appetite, energy, concentration, motivation, and pleasure — that persist for at least two weeks and meaningfully interfere with daily life. The line between "going through a hard time" and "experiencing clinical depression" is partly about duration and partly about function: when the symptoms start to limit work, relationships, or basic self-care, the situation has crossed a threshold worth taking seriously.

Second: depression is rarely just one thing. It tends to take a particular shape in each person — what specific symptoms dominate, what triggers a worse week, what helps and what doesn't. Understanding that shape is part of the path to feeling better, because what works for one form of depression often works less well for another. The post will get to this in §II.

Third: depression is highly treatable, and the evidence on what works is more robust than the public conversation usually acknowledges. But "treatable" does not mean "easy." It means the average person who engages with one of the well-evidenced pathways shows measurable improvement — not a guarantee, not overnight, and not for everyone. Realistic expectations are part of care. §IV walks through the five pathways with their honest effect sizes.

Fourth: getting help in the United States is logistically harder than it should be. Therapist availability, insurance complications, cost, geographic gaps, and the time required for an initial intake all create real friction. The post does not pretend these barriers don't exist; it offers practical ways to navigate them in §V.

Finally: depression is rarely a one-time event. About half the people who experience one episode will experience another at some point. The well-evidenced practice of relapse prevention — particularly mindfulness-based cognitive therapy — cuts that recurrence rate by roughly 40%. The post talks about what comes after a first recovery in §VI, because that is the part most depression content skips.

If you are currently in crisis or having thoughts of harming yourself, please consider stopping here and calling or texting 988, the Suicide and Crisis Lifeline. It is free, confidential, and available 24 hours a day. The rest of this post will be here when you are ready.

§II.What depression actually is (and isn't)

The English word "depression" carries too much weight. It is used to describe a sad afternoon, a bad week, a difficult year, and a serious clinical condition that affects millions of people — all with the same word. This makes the territory hard to navigate. A person who notices they have been feeling low for a while has no easy way to tell whether they are experiencing something that will pass on its own, something that calls for a conversation with a friend or a partner, or something that calls for clinical care. The language doesn't help them sort it out.

Some distinctions are useful.

Sadness is a mood. It is a normal human response to disappointment, loss, frustration, or a hard day. It tends to be tied to something — a recent event, a specific situation, a particular thought — and it tends to lift within hours or days. A sad person can usually still enjoy things they normally enjoy. They can usually still concentrate, still sleep, still feel pleasure. Sadness is uncomfortable, but it functions.

Grief is the cluster of feelings that follows a significant loss — a death, a divorce, a major life change, a serious illness, the end of something important. Grief looks a lot like depression on the surface. It involves low mood, loss of interest in ordinary activities, sleep disruption, fatigue, and sometimes profound hopelessness. But grief is contextual: it is a response to a specific event, and the symptoms tend to wax and wane in connection with reminders of the loss. Grief can take months or years to soften, and it is not pathological. It is part of how human beings process loss.

Burnout is a state of physical and emotional exhaustion that builds up over time, usually in response to chronic stress at work or in caregiving. It involves fatigue, cynicism, reduced effectiveness, and a sense of detachment from one's work or role. Burnout shares some symptoms with depression — particularly the exhaustion and the cynicism — but it tends to be specifically tied to a role or a stressor, and it often improves significantly when the stressor is removed or reduced.

Clinical depression is something else. It involves a sustained period of low mood or loss of interest — at least two weeks, often much longer — alongside a cluster of other symptoms that meaningfully interfere with daily life. The line between a bad stretch and clinical depression is often about three things: duration, breadth, and function.

• Duration: Symptoms have lasted at least two weeks, not days.
• Breadth: It is not just one symptom (low mood) but a cluster — sleep, appetite, energy, concentration, motivation, self-perception, sometimes thoughts of self-harm.
• Function: The symptoms are interfering with what the person normally does — work, relationships, self-care, the ordinary maintenance of a life.

Clinicians sometimes describe the difference this way: sadness is about feeling bad, while depression is about being unable to feel good. A person experiencing sadness can often still laugh at a joke, enjoy a meal, look forward to a weekend. A person experiencing depression often cannot — or can only weakly, and only briefly. The flatness, more than the heaviness, is what tends to make depression recognizable from the inside.

The three faces of depression

Within the broad category of clinical depression, there is significant variation in how it shows up in any given person. The standard nine-criterion framework used by clinicians worldwide — and adapted in instruments like the PHQ-9 (Kroenke, Spitzer & Williams, 2001) — groups the nine symptoms into three loose clusters. These are not formal diagnostic subtypes, but they are useful for understanding the shape of what someone is experiencing.

The cognitive-emotional face is what most people imagine when they think of depression. It is the low mood, the persistent sense of hopelessness, the harsh self-criticism, the feeling of worthlessness or guilt, the difficulty concentrating or making decisions. It is the depression that shows up in thought patterns — the inner voice that has gone dark, the rumination on past mistakes, the inability to imagine a better future. For many people, this is the most distressing part. It is also the part that responds particularly well to cognitive-behavioral therapy, which was originally designed to target exactly these thought patterns.

The physical face is the depression that lives in the body. It is the sleep that has gone wrong — too much or too little, broken or shallow. It is the appetite changes that come with no clear reason. It is the fatigue that doesn't lift with rest, the slowed-down quality of movement and speech, or its opposite — the restless agitation that some people experience instead. The physical symptoms are often what first prompt people to consider that something is wrong, but they are also the symptoms most easily attributed to other causes: a busy season, a hard week, poor sleep hygiene, a virus. This is the face of depression that often gets missed for the longest.

The pleasure-motivation face — what clinicians call anhedonia — is the loss of interest or pleasure in things that used to feel good. The favorite show that no longer pulls. The hobby that has gone cold. The friend whose company used to feel like a gift and now feels like effort. The relationship to one's own life that has become distant, flat, observational. For many people experiencing depression, this is the face that is hardest to describe to others, because the absence of feeling is harder to articulate than the presence of pain. Anhedonia is the depression of "I don't know — I just don't really care anymore." It is also a strong predictor of how serious the episode is, and how much it warrants attention.

Most people who experience depression have all three faces showing up to some degree, but in different proportions. Some people are dominated by the cognitive-emotional face — a relentless, hopeless inner narrative. Others are dominated by the physical face — exhaustion and disrupted sleep that drag everything else with them. Others are dominated by anhedonia — a quiet greying-out of life that they sometimes don't even register as depression until someone names it for them.

Understanding which face is dominant matters because it shapes what kind of help is likely to work first. The cognitive-emotional face often responds well to cognitive therapy. The physical face often responds to behavioral activation, exercise, and sleep restoration. The pleasure-motivation face often responds to behavioral activation combined with a careful rebuilding of small, accessible sources of pleasure and meaning. None of these pathways are mutually exclusive. The science on this is more granular than the public conversation suggests, and §IV gets into the specifics.

§III.Recognizing it in yourself

One of the most uncomfortable aspects of depression is that the person experiencing it often does not recognize it. The condition tends to feel like an accurate description of the world rather than a temporary state. "I am tired because of work." "I just don't enjoy that anymore." "I've always been a slow starter in the morning." Each of these can be true, and each can also be a way the mind protects itself from the harder thought: something has changed, and I am not sure when.

The most reliable cue is not a single symptom but a pattern that has lasted longer than a couple of weeks and that has started to affect daily functioning. Clinicians sometimes use a short mental checklist when they are trying to decide whether someone's experience has crossed the threshold from "having a hard time" into "something worth taking seriously":

• Has my mood, energy, or interest in things noticeably shifted for two or more weeks? Not a bad day. Not a tough week. A stretch.
• Am I doing the things I normally do? Work, school, family, friends, eating, sleeping, basic self-care. If yes, but with significantly more effort, that counts. If some of these have started slipping, that counts more.
• Do small things feel disproportionately heavy? Replying to a text. Opening the mail. Making a phone call. The disproportion is informative.
• Has my relationship to pleasure changed? Foods that used to taste good. Conversations that used to feel warm. Music that used to land. The flatness is one of the most consistent markers.
• Am I having any thoughts of being better off not here, or of hurting myself? Even fleeting ones, even ones you would dismiss as "not really meaning it." These deserve a clinical conversation, not silence.

None of these questions is diagnostic. They are recognition prompts — the kind of thing a thoughtful clinician would ask in a first appointment to begin to understand the texture of what someone is experiencing. The function of the list is not to put a label on a feeling, but to give the feeling enough shape that it can be discussed with someone qualified to help.

Self-administered screening instruments serve a similar role, with the added benefit of producing a number that can be tracked over time. The most widely used in primary care is the PHQ-9, a nine-item questionnaire developed by Kroenke, Spitzer, and Williams in 2001 and now translated into more than forty languages. It is not a diagnostic test. It is a screening tool: a way of organizing nine relevant symptoms into a 0-to-27 score that points to whether a clinical evaluation is warranted. The same nine criteria form the basis of the LifeByLogic Depression Test, which is browser-local, free, and includes a care-aware crisis architecture that connects directly to the 988 Lifeline if a respondent reports any thoughts of self-harm. The LBL version is written in original LifeByLogic language with five severity bands, a profile of which symptom dimensions are most active, and a brief description of the shape of what someone is experiencing — not just its intensity.

For most people, a screen serves as a translation device. It takes the diffuse weight of "something is off" and converts it into language and a number that a primary care doctor or therapist can engage with directly. That conversation, more than the score itself, is the point.

What the population-level numbers look like

To give a sense of context, the chart below shows how depression scores distribute across the US population age 12 and older, based on the most recent NHANES data (2021–2023). The five severity bands — minimal, mild, moderate, moderately severe, and severe — correspond to the standard PHQ-9 score ranges used in research and clinical settings.

Two things are worth noticing about this distribution. The first is that the moderate-and-above population — the 13% — is genuinely large in absolute numbers. In a US population of about 330 million, this corresponds to roughly 30 million people scoring at or above the threshold at any given time. The second is that the mild range — the 5-to-9 band — captures another 16% of the population, about 36 million more people. The mild range does not always warrant clinical treatment, but it does correspond to symptoms that affect daily life, and it is the band from which people most often slide into the moderate range during a difficult life period.

The distinction that most matters, from a recognition standpoint, is not the precise number on a screen. It is functional impairment. The PHQ-9 includes a tenth item — separate from the nine summed items — that asks how difficult the symptoms have made it to do work, take care of things at home, or get along with other people. Clinicians treat this as a stronger actionable signal than the total score. A person with a score of 7 who reports severe functional impairment may warrant more clinical attention than a person with a score of 12 who reports minimal impairment. The number describes the symptoms. The impairment describes whether the symptoms are interfering with a life.

If you have been reading along and finding yourself recognizing some of what is described — a stretch of weeks in which something has shifted, some flattening of pleasure, some difficulty with the ordinary maintenance of life — the most useful next step is usually to put a name on it with someone qualified to help. §V walks through what that practically looks like. Before getting there, §IV addresses the question that often comes first: what actually works for depression?

§IV.What actually works

The evidence on depression treatment is, on balance, more positive than the public conversation suggests. Multiple independent treatment pathways have been validated across decades of randomized controlled trials and meta-analyses. The best-evidenced therapies produce moderate to large effect sizes — meaning the average treated person ends up clearly better than the average untreated person, by a margin that matters in everyday life. Around 60 to 70% of people who engage with one of the well-evidenced pathways show clinically significant improvement. That is not 100%. But it is also not the resigned "nothing really helps" picture that pessimistic readings of mental health coverage sometimes leave behind.

The harder truth lives inside that aggregate. Different pathways work better for different people, depending on the shape of their depression, their personal circumstances, their access to care, and frankly their willingness to try. Recovery is rarely linear. People often try one approach, find it insufficient, try another, find that one helps more, and end up with a combination that fits their life. The five pathways below are the ones with the most robust evidence. They are not mutually exclusive, and most people who recover use more than one.

1. Psychotherapy: cognitive behavioral therapy and behavioral activation

Cognitive behavioral therapy (CBT) for depression is one of the most studied psychological interventions in the history of clinical research. The largest meta-analyses (Cuijpers et al. 2013; Cuijpers et al. 2020 update) consistently show moderate-to-large effect sizes — roughly equivalent to those produced by antidepressant medication, with longer-lasting protection against relapse. CBT works by helping a person identify the thought patterns that depression characteristically produces — the harsh self-judgments, the certainty that things will not improve, the interpretive frame that turns every setback into evidence of personal failure — and develop ways of testing those thoughts against reality.

The version of CBT that has emerged with the strongest evidence for severe or chronic depression is behavioral activation (Dimidjian et al. 2006; Ekers et al. 2014). It is, in some ways, the simpler half of the CBT toolkit. Where cognitive therapy focuses on changing thought patterns, behavioral activation focuses on changing actions: identifying the activities that used to produce mood, meaning, or mastery; scheduling them in deliberately and at scale; and noticing what the doing does to the mood, often before the mood is fully ready to cooperate. The principle behind it is that in depression, motivation typically follows action rather than preceding it. Waiting until one feels like doing something tends to wait forever; doing the thing — often with a clinician's structured support — tends to bring the feeling back in pieces.

For mild to moderate depression, evidence-based psychotherapy is generally a first-line recommendation. Twelve to twenty sessions, weekly, is the typical course. Most people see noticeable improvement by week four to six and substantial improvement by week twelve. Online and app-based CBT programs (such as those tested in the NHS's Improving Access to Psychological Therapies program) produce smaller but still meaningful effects for people who cannot access in-person care.

2. Exercise as treatment, not just lifestyle

One of the most underappreciated facts in depression treatment is that structured exercise produces antidepressant effects of a magnitude that would, in any other context, be considered a major treatment finding. The Cochrane review of exercise for depression (Cooney et al. 2013, with subsequent updates) found that exercise produced effects comparable to psychological therapies in head-to-head comparisons, and clinically meaningful effects when compared to no treatment. A more recent network meta-analysis (Noetel et al. 2024, published in BMJ) found that for mild to moderate depression, structured exercise produced effects similar to therapy and antidepressants — particularly walking, jogging, yoga, and resistance training.

What is striking about the exercise evidence is not just the effect size but the dose-response: more is better up to a point, and even modest doses — around 150 minutes per week of moderate activity, or shorter sessions of higher intensity — produce measurable benefit. The catch is that depression itself makes exercise harder to initiate, which is precisely the obstacle behavioral activation is designed to address. For people whose depression has a strong physical face — exhaustion, sleep disruption, low energy — exercise is often the lever that begins to move other symptoms.

3. Medication: what the honest evidence shows

Antidepressant medication is one of the most well-studied and most contested treatments in medicine. The honest picture sits between two unhelpful framings. On one side, the framing that antidepressants are a chemical fix that should work for everyone and that anyone who doesn't improve is doing something wrong. On the other side, the framing — popularized in some recent press coverage — that antidepressants barely outperform placebo and are essentially marketing. Neither is accurate.

The most rigorous meta-analysis to date (Cipriani et al. 2018, published in The Lancet) analyzed 522 trials of 21 antidepressants and found that all 21 outperformed placebo for major depression, with effect sizes ranging from small (sertraline, fluoxetine) to moderate (amitriptyline, mirtazapine). The average effect size is modest but real: roughly one in seven people who would not have responded to placebo will respond specifically to the medication. For severe depression — depression at the more impairing end of the spectrum — the effects are larger and more consistent.

Practically: SSRIs (selective serotonin reuptake inhibitors, such as sertraline, escitalopram, fluoxetine) are usually the first-line medication choice because of their relatively benign side effect profile. They take 2 to 4 weeks to begin working and typically 6 to 8 weeks to reach full effect. About 40 to 50% of people respond to the first medication they try; another 20 to 30% respond to a second; some need a third or a combination. The decision to use medication, what to use, and how long to use it is appropriately a clinical conversation, not a self-directed experiment. For people considering it: medication and therapy are not in opposition. Combined treatment outperforms either alone for moderate-to-severe depression.

4. Mindfulness-based cognitive therapy (for relapse)

Mindfulness-based cognitive therapy (MBCT) is an eight-week structured group program that combines elements of cognitive therapy with mindfulness practices adapted from secular meditation traditions. Its primary use case is not first-episode depression but relapse prevention in people who have had multiple prior episodes. The largest individual-patient-data meta-analysis (Kuyken et al. 2016, published in JAMA Psychiatry) found that MBCT reduced depression recurrence by approximately 40% over the following 60 weeks, compared to usual care. The protective effect was particularly strong in people who had experienced three or more prior episodes.

What MBCT teaches, in essence, is a different relationship with the early-warning signals of an oncoming depressive episode — the familiar negative thought patterns, the small withdrawals, the early shifts in sleep or appetite. Rather than reacting to these signals with the despair of "here it comes again," MBCT-trained participants learn to notice the signals as transient mental events and to deploy specific techniques (often a brief breathing or grounding practice) that interrupt the slide before it accelerates. It is less about feeling calm and more about responding skillfully to the patterns one's own mind tends to produce.

5. Lifestyle infrastructure

The fifth pathway is less glamorous than the others but quietly important. Sleep regularity, social connection, daily structure, and exposure to natural light all produce modest but cumulative antidepressant effects. None is sufficient on its own to treat severe depression. All become more impactful in combination, and all become more sustainable when integrated into a treatment plan that also includes therapy, exercise, and (where appropriate) medication.

The specific elements with the most evidence: sleep regularity (consistent bedtime and wake-time, even across weekends) protects mood; sleep deprivation worsens it. Social connection — even brief, low-pressure interactions with people who know you — has a measurable effect on mood and a protective effect against suicide. Daily structure — having things to do, in a predictable order, at predictable times — provides what behavioral activation provides at a smaller scale, and is one of the first things to erode when depression takes hold. Light exposure, particularly morning light, supports circadian rhythm and has a modest but reliable antidepressant effect that is amplified for people with seasonal depression patterns.

What this all adds up to

For mild depression, lifestyle changes and either psychotherapy or exercise often suffice. For moderate depression, psychotherapy is typically first-line, often supplemented with exercise and lifestyle changes. For moderate-to-severe depression, combined therapy and medication tend to outperform either alone. For recurrent depression, the addition of MBCT or maintenance therapy substantially reduces relapse risk. None of these recommendations is universal; each is a starting point for a clinical conversation that takes into account the specific shape of someone's depression, their history, their preferences, and their access.

What is consistent across the evidence is this: most people who engage with the well-evidenced pathways improve, and the improvement tends to compound. The path is rarely linear, and the first thing tried is not always the thing that ends up working best. But the underlying picture — that depression is highly treatable, that the science is solid, and that the gap between effective options and the people who need them is the central problem — is well-supported.

The treatment gap

Which brings us back to the original number. Despite the breadth and depth of the evidence on what works, roughly half of US adults with mental illness — including many with depression — receive no treatment at all in any given year. The gap is largest among young adults and adolescents.

The reasons for the gap are layered. Cost is the single most cited reason — about 28% of people who need but did not receive mental health care in 2024 said cost was the primary barrier (SAMHSA NSDUH 2024). But cost is followed closely by other barriers that often go undiscussed: not knowing where to start, uncertainty about whether what they are experiencing "counts," the time required for an initial intake, the difficulty of finding a therapist who is taking new clients and is in-network, and the lingering stigma — particularly around medication — that makes some people reluctant to begin even when access is available.

The next section is about how to close the gap practically. It walks through the action sequence that takes someone from "I think I might have this" to "I have a plan" — the steps, in order, that the system is least good at explaining.

§V.From "I think this might be me" to "I have a plan"

The action sequence that takes a person from recognizing that they might be experiencing depression to actually receiving care is, in the United States, more confusing than it should be. There is no single official guide that walks someone through the steps in order. This section is an attempt at one. Adjust it to your circumstances, take what is useful, and skip what does not apply.

Step 1: Decide what kind of starting conversation makes sense

There are three reasonable first conversations, each with different friction and different strengths.

Primary care doctor. If you already have a primary care physician, an appointment to discuss what you have been experiencing is often the simplest first step. Most primary care doctors are familiar with the PHQ-9, can administer a brief screening in-office, can prescribe an SSRI if appropriate, and can refer you to a therapist or psychiatrist as needed. The advantages: low friction (you already have the relationship), insurance generally covers it, and a primary care doctor can address overlapping physical issues (thyroid, sleep, medication interactions) that sometimes contribute. The limitation: a primary care visit is short, and most primary care doctors are not in a position to provide ongoing therapy themselves.

Therapist or licensed counselor. A therapist will provide the structured psychological treatment described in §IV. The friction is higher: finding a therapist who is accepting new clients, is in-network with your insurance, and who specializes in depression or evidence-based therapies like CBT or behavioral activation often requires research. Psychology Today's therapist directory (psychologytoday.com/us/therapists) is the most commonly used starting point; it allows filtering by location, insurance, and specialty. Once you find candidates, expect a brief phone consultation before the first session.

Psychiatrist. A psychiatrist is a medical doctor who specializes in mental health and can prescribe medication. Most psychiatrists in current US practice focus on medication management rather than ongoing therapy. If you suspect medication will be part of your treatment — particularly if symptoms are severe, if there is a family history of depression that responded to medication, or if previous therapy alone has been insufficient — starting with a psychiatrist can make sense. The friction is highest: psychiatrist waitlists in many US markets are months long. Many people start with a primary care doctor and add a psychiatrist later if medication management becomes the central need.

Step 2: Navigating cost and insurance

The cost barrier is real but more navigable than it sometimes appears. Concrete options, roughly in order of ease:

• Insurance: If you have insurance, call the number on the back of your card and ask for a list of in-network mental health providers. Mental health parity laws require commercial insurers to cover mental health care at parity with medical care, though enforcement varies. Asking for an updated list of providers accepting new clients can save considerable time.
• Employee Assistance Program (EAP): Most US employers with more than 50 employees offer an EAP that provides 3 to 8 free therapy sessions per year. Many people who have an EAP do not realize it. Check with HR or your employee portal.
• Sliding-scale therapists: Open Path Collective (openpathcollective.org) lists therapists offering sessions at $30 to $80, with a one-time $65 membership fee.
• Federally Qualified Health Centers (FQHCs): FQHCs provide care on a sliding fee scale based on income, regardless of insurance status. Find your nearest one at findahealthcenter.hrsa.gov.
• Community mental health centers: Most US counties operate at least one, often with bilingual staff and reduced or free care for low-income residents.
• University training clinics: If you live near a university with a clinical psychology or social work program, the training clinic typically offers low-cost therapy with supervised graduate students. Effect sizes for supervised training-clinic care are comparable to those of licensed therapists.
• Online platforms: Services like BetterHelp and Talkspace are more accessible and often less expensive than in-person care, though quality varies and insurance coverage is inconsistent. They tend to work better for mild-to-moderate depression than for severe.

Step 3: What to expect at a first appointment

The first appointment with a therapist is usually 50 to 60 minutes. It is mostly information gathering: the therapist will ask about what brought you in, how long the symptoms have been present, your medical history, family history of mental health conditions, any past treatment, and what you are hoping to get out of therapy. They will likely administer or discuss a screening tool. They may not offer specific interventions in the first session — that often starts in session two or three, once they have a clearer picture.

A first appointment with a primary care doctor about depression is usually 15 to 30 minutes. They will likely administer a PHQ-9 or similar screen, ask about symptom duration and impact, screen for medical conditions that can mimic depression (thyroid issues, vitamin deficiencies, sleep disorders), and discuss next steps. If medication is appropriate, they may prescribe a starting dose of an SSRI and schedule a follow-up in 4 to 6 weeks to assess response.

It is normal and reasonable to bring notes — a few sentences describing what you have been experiencing, when it started, how it has affected your daily life. Many people find that having something written down helps when they are trying to describe symptoms that are hard to put into words on the spot.

Step 4: What if the first thing doesn't help

Treatment-resistant depression is not the same as untreatable depression. Roughly 30 to 40% of people do not respond fully to the first medication or therapy they try. In a well-run treatment process, this is anticipated, not catastrophic. The standard sequence — increase the dose, switch to a different SSRI, switch class, add an augmenting agent, try a different therapy modality, consider combination treatment — has been studied extensively (most prominently in the STAR*D trial). Many people who do not respond to the first treatment respond to the second or third. Persistence with the process, supported by a clinician who can adjust the plan, is part of what works.

If treatment is not progressing as expected after 8 to 12 weeks of a given approach, this is a conversation to have explicitly with the clinician. "What I'm doing isn't working as much as I hoped — what are the options?" is a reasonable thing to say, and a competent clinician will welcome it.

§VI.What comes after

Most depression content stops at "get help." This is the part it usually skips.

Depression is a condition that has a particular shape over time. About half the people who experience a first episode of major depression will experience another at some point. Each subsequent episode increases the probability of further recurrence. This is one of the most well-established facts in depression research and one of the most useful to know in advance. It is not a verdict. It is information that shapes the kind of relationship a person builds with their own mental health going forward.

The most well-evidenced practice for relapse prevention is the one already mentioned in §IV: mindfulness-based cognitive therapy. The Kuyken et al. 2016 meta-analysis in JAMA Psychiatry (Kuyken W, Warren FC, Taylor RS, et al. 2016), pooling individual patient data from nine randomized trials, found that MBCT reduced recurrence by approximately 40% over the 60 weeks following treatment. The protective effect was particularly strong for people who had experienced three or more prior episodes. For those people, MBCT outperforms ongoing antidepressant maintenance in some comparisons. For others, the two combine well.

Beyond MBCT specifically, the broader pattern is that recovery is best understood as an ongoing practice rather than a destination. People who do well over the long term tend to maintain some version of the things that helped them in the first place: a therapeutic relationship they can return to even when they are mostly well, a movement practice that has become a habit, attention to sleep and to social connection, and an early-warning system for the patterns that signal an oncoming episode. The system is not elaborate. It is more like dental hygiene than like medicine — small, consistent, ongoing.

This is also where the spider diagram below becomes useful. It shows depression not as a number but as a shape across five life domains. The "typical week" profile is what life feels like when the system is broadly working. The "moderate depression" profile is what changes when an episode arrives. People who become familiar with what their own version of the depression shape looks like — which domains tend to shift first, which ones lag, which ones recover fastest — gain a kind of early-warning capacity that the unprepared mind doesn't have.

The other thing that comes after, and that is often left unsaid, is that depression is part of a life rather than the whole of one. People who have experienced depression often describe the recovered version of themselves as somewhat changed by the episode — sometimes in difficult ways, sometimes in valuable ones. Many describe a clearer sense of what matters to them, a more deliberate approach to managing their own well-being, and a particular kind of compassion for other people in difficulty. The episode is not a thing to be forgotten. It is a thing that becomes integrated, sometimes uncomfortably, into a continuing life.

Stigma is the last piece. The cultural shift around depression has been real over the past two decades — celebrities discussing it publicly, employers offering mental health benefits, language that has softened — but stigma remains, particularly for men, for people in certain professional contexts, and for people in communities where the cultural framing is unsupportive. The most reliable counter to stigma is not argument but normalization. Most people, in some period of their lives, will experience either a depressive episode themselves or watch someone they love go through one. The condition is common. The treatment works. The shame is a residue of a previous era, and it is worth declining to inherit it.

The next section answers the eight questions that most often come up after a piece like this.